Benefits of Boswellia Serrata Capsules
Key Findings
Supplements containing Boswellia serrata and Harpagophytum procumbens have demonstrated significant benefits in reducing pain and improving joint function in patients with knee osteoarthritis [1] [2] [3].
The combination of these extracts has shown anti-inflammatory, antioxidant, and chondroprotective properties, contributing to improved quality of life and reduced reliance on conventional pain medications [4] [5].
Clinical trials indicate a good tolerability profile with few adverse effects, making them a promising alternative or adjuvant therapy for osteoarthritis [2] [3].
Introduction
Osteoarthritis (OA) is a prevalent degenerative joint disease characterized by inflammation, pain, and reduced mobility. While non-steroidal anti-inflammatory drugs (NSAIDs) are commonly used, their associated cardiovascular and gastrointestinal side effects have led to increased interest in alternative treatments, including nutraceuticals. Boswellia serrata and Harpagophytum procumbens (Devil's Claw) are two such herbal extracts recognized for their anti-inflammatory, analgesic, and chondroprotective properties, often used in combination to manage OA symptoms [4] [6]. This report discusses the benefits of a supplement containing 100mg Boswellia serrata and 70mg Harpagophytum procumbens for human health, primarily focusing on knee osteoarthritis.
Main Text
Benefits in Osteoarthritis Management
Several studies highlight the effectiveness of Boswellia serrata and Harpagophytum procumbens in managing osteoarthritis symptoms. A multicenter, randomized, double-blind, controlled, crossover study involving 88 patients with knee OA found that a combination of Boswellia serrata extract and Harpagophytum procumbens extract (Loxacon®) alongside physical therapy resulted in a twice as large improvement in functionality compared to physical therapy alone or with placebo [1]. Another post-marketing clinical evidence generation program with 105 patients (mean age 58-65 years) receiving TriNyros (containing Rosehip, Harpagophytum procumbens 100 mg, and Boswellia serrata 50 mg) twice daily for 90 days reported a significant reduction in WOMAC pain scores by 58.82% and VAS pain scores by 67% at the end of the treatment period [2]. Similarly, a phase IV surveillance study with 151 OA patients showed a significant reduction in WOMAC scores from 39.62 to 13.36 after 90 days of TriNyros supplementation [3]
Mechanisms and Broader Applications
The therapeutic effects of these botanicals stem from their ability to balance anabolic and catabolic processes in joint tissue, improve redox balance, and scavenge free radicals, thereby providing cartilage protection [4]. Harpagoside, an active component of Harpagophytum procumbens, modulates pathways like NF-κB and targets inflammation, oxidative stress, and pain [7]. Boswellia serrata also demonstrates potent anti-inflammatory, anti-arthritic, and analgesic actions [8]. A systematic review and meta-analysis of seven trials involving 545 OA patients concluded that Boswellia or its extract significantly relieved pain (VAS: WMD -8.33; WOMAC pain: WMD -14.22), stiffness (WOMAC stiffness: WMD -10.04), and improved joint function (WOMAC function: WMD -10.75) compared to control groups [8]. Beyond OA, a phytotherapic formulation including Curcuma, Boswellia essential oils, Harpagophytum procumbens root, and Bromelain reduced oxidative stress by 20% and improved mitochondrial function in an in vitro model of atorvastatin-induced cardiomyopathy, suggesting broader protective effects [9].
Conclusions
Supplements containing Boswellia serrata and Harpagophytum procumbens offer significant benefits for human health, particularly in the management of osteoarthritis. Clinical evidence demonstrates their efficacy in reducing pain, improving joint function, and enhancing the overall quality of life for individuals with knee OA. Studies have reported substantial reductions in pain, with WOMAC pain scores decreasing by up to 58.82% and VAS pain scores by 67% in treated patients [2]. These natural extracts exert anti-inflammatory, antioxidant, and chondroprotective effects, supporting cartilage health and reducing reliance on conventional pain medications [4] [5]. The combination of these ingredients is generally well-tolerated, presenting a valuable adjunctive or alternative therapeutic option for managing inflammatory and degenerative joint conditions [2] [3].
References:
1) T Bender et al. Investigating the Additive Effects of Loxacon® Food Supplement Capsules in Patients with Knee Osteoarthritis. A Multicenter, Randomized, Double-Blind, Controlled, Crossover, Follow-Up, Three-Arm Study. Journal of medicinal food (2024). https://pubmed.ncbi.nlm.nih.gov/39446666/
2) Dr. Gautam Chakraverty et al. Clinical benefits and risk assessment of TriNyros in osteoarthritis of the knee: BRATO evidence generation program. International Journal of Orthopaedics Sciences (2020). https://doi.org/10.22271/ortho.2020.v6.i4n.2444/
3) Dr. Sachin Tapasvi et al. Clinical efficacy of nutraceuticals in the management of osteoarthritis. International Journal of Orthopaedics Sciences (2022). https://doi.org/10.22271/ortho.2022.v8.i3a.3166/
4) Sachin Tapasvi et al. Role of Rosehip, Devil’s claw, and Boswellia serrata in osteoarthritis: molecular and clinical perspectives. International Journal of Orthopaedics Sciences (2023). http://dx.doi.org/10.22271/ortho.2023.v9.i1h.3346/
5) Z Żęgota et al. Prospective, Multicenter Evaluation of a Polyherbal Supplement alongside Standard-of-Care Treatment for Mild Knee Osteoarthritis. Advances in orthopedics (2021). https://pubmed.ncbi.nlm.nih.gov/34035964/
6) Sigrun Chrubasik et al. Osteoarthritis: Pharmacology and clinical indications of selected botanicals. The Pain Clinic (2004). https://doi.org/10.1163/156856904322858648/
7) H Kaur et al. Decoding the mechanistic landscape of harpagoside: From molecular targets to translational pharmacology. Fitoterapia (2025). https://pubmed.ncbi.nlm.nih.gov/41391813/
8) G Yu et al. Effectiveness of Boswellia and Boswellia extract for osteoarthritis patients: a systematic review and meta-analysis. BMC complementary medicine and therapies (2020). https://pubmed.ncbi.nlm.nih.gov/32680575/
9) MG Nasoni et al. The Activity of Phytotherapic Extracts Combined in a Unique Formulation Alleviates Oxidative Stress and Protects Mitochondria Against Atorvastatin-Induced Cardiomyopathy. International journal of molecular sciences (2025). https://pubmed.ncbi.nlm.nih.gov/40430054/